| Protocol No. | PI | Title |
|---|
| OSU-0107 | Doreen Agnese | Prospective Cohort Study of BRCA1 & BRCA2 Carriers |
| OSU-10129 | Dawn Allain | The Value of Genetic Counselors in Genetic Testing for Hereditary Breast-Ovarian Cancer |
| OSU-06016 | Sanford Barsky | The Bone marrow Stem Cell Origin of Solid Cancers in Humans and Transgenic Mice. |
| OSU-06017 | Sanford Barsky | Clues to the Stem Cell Origin of Human Cancers by Studying a Registry of Organ Transplant Recipients. |
| OSU-06056 | Sanford Barsky | Use and Validation of Virtual Algorithms on TMA and Individual Microscope Slides to Detect Cancer Cells and Quantitate Immunocytochemical Staining for Select Nuclear, Cytoplasmic and Membrane Antigens. |
| CALGB-9760 | Clara Bloomfield | Multidrug Resistance Studies in AML |
| CALGB-9862 | Clara Bloomfield | Molecular Features of Acute Lymphoblastic Leukemia |
| CALGB-8461 | Clara Bloomfield | Cytogenetic Studies in Acute Leukemia [Dr. Clara Bloomfield, National Study Chair] |
| OSU-1997CO194 | Michael Caligiuri | OSUCCC Leukemia Tissue Bank |
| OSU-07030 | William Carson | Analysis of Micro-RNA Species in Melanoma. |
| OSU-13114 | William Carson | A Storage Facility for Tissues Obtained from Patients with Malignant Melanoma.
|
| OSU-12140 | Arnab Chakravarti | Molecular markers of prostate carcinoma |
| OSU-09024 | Beth Christian | A phase I/II study of veltuzumab (IMMU-106, hA20), a humanized anti-CD20 monoclonal antibody, combined with milatuzumab (IMMU-115, hLL1), a humanized anti-CD74 monoclonal antibody, in relapsed and refractory B-cell non-Hodgkin's lymphoma |
| OSU-06036 | Frederick Davidorf | Genetics of Hereditary Uveal Melanoma. |
| OSU-0358 | Frederick Davidorf | Molecular Genetic Profiling of Uveal Melanomas |
| OSU-05090 | Albert de la Chapelle | Storage of Biological Material for the Discovery and Characterization of Genes Involved in Hereditary Disease Predisposition. |
| OSU-9812 | Albert de la Chapelle | A Strategy to Search for Genes Predisposing to Papillary Carcinoma of the Thyroid When Mutated |
| OSU-9952 | Albert de la Chapelle | Storage of DNA/RNA for the Discovery of Genes Involved in Cancer Predisposition - A Tissue Collection Study |
| OSU-06005 | Albert de la Chapelle | Characterization of Mutations in the PMS2 Gene in Samples from the Human Cancer genetics Sample Bank. |
| OSU-07013 | Albert de la Chapelle | The Identification of Predisposing Genes in Hyperplastic Polyposis (HPP) |
| OSU-09060 | Albert de la Chapelle | Evaluation of In Vivo and In Vitro Pharmacology and Toxicology of Preventive Agents by Proteomics Using Human Mutant Cells from Dominantly Heritable Cancers: Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer (HNPCC) |
| OSU-07087 | Albert de la Chapelle | Characterization of Potential Susceptibility Genes in Chronic Lymphocytic Leukemia (CLL) |
| OSU-11002 | Yvonne Efebera | Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease |
| OSU-10130 | James Elder | NIH 1308: The Cancer Genome Atlas Patient Enrollment and Specimen Qualification Criteria Grade II-IV Gliomas |
| OSU-12194 | Michael Grever | Clinical Research in Hairy Cell Leukemia: Surveillance and Documentation of Clinical Outcomes in a Rare Form of Adult Leukemia
|
| OSU-0449 | Denis Guttridge | Assessment of NFkB in Muscle Wasting Associated with Cancer-Induced Cachexia |
| OSU-05059 | Tsonwin Hai | Investigation of a Potential New Oncogene |
| OSU-10115 | Craig Hofmeister | Buckeye Surveillance, Contact, and Research for Multiple Myeloma and Amyloidosis |
| OSU-06032 | Richard Kloos | The Endocrine Neoplasia Repository (ENR). |
| OSU-11126 | Richard Kloos | Salivary gland damage and dysfunction in patients with differentiated thyroid cancer treated with radioactive iodine. |
| OSU-0456 | Jas Lang | Tissue Procurement and Database for the Study of Molecular Events in Primary, Recurrent, and Metastatic Squamous Cell Carcinoma of the Head and Neck. |
| OSU-12042 | Greg Lesinski | The Effect of a Soy Bread Diet Intervention on Immune Function in Men with Prostate Cancer |
| OSU-05019 | Guido Marcucci | Assessment of Aberrant Expression of Leukemic Markers in Normal CD34+ Hematopoietic Precursors. |
| OSU-05061 | Guido Marcucci | Molecular Studies in Acute Myeloid Leukemia |
| CALGB-9665 | Guido Marcucci | Leukemia Tissue Bank [Dr. Michael Caligiuri, National Study Chair] |
| OSU-07110 | Amir Mortazavi | Optimizing Human Urine Protein Extraction |
| OSU-12129 | Thomas Olencki | The High-Dose Aldesleukin (IL-2) "Select" Trial: A PROSPECTIVE TISSUE COLLECTION PROTOCOL TO INVESTIGATE PREDICTIVE MODELS OF RESPONSE TO HIGH DOSE IL-2 TREATMENT IN PATIENTS WITH ADVANCED MELANOMA
|
| OSU-12183 | Greg Otterson | A Single-Arm Phase 2 Study of BMS-936558 in Subjects with Advanced or Metastatic Squamous Cell Non-Small Cell Lung Cancer Who Have Received At Least Two Prior Systemic Regimens |
| OSU-12184 | Greg Otterson | Lung Cancer Mutation Consortium Protocol |
| OSU-12053 | Greg Otterson | A Randomized Phase II Trial of Erlotinib Alone or In Combination with Bevacizumab in Patients With Non-Small Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations |
| OSU-12068 | Greg Otterson | LUX-Lung 8: A randomized, open-label Phase III trial of afatinib versus erlotinib in patients with advanced squamous cell carcinoma of the lung as second-line therapy following first-line platinum-based chemotherapy |
| OSU-11144 | Greg Otterson | A RANDOMIZED, PHASE III, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF MetMAb IN COMBINATION WITH TARCEVA (ERLOTINIB) IN PATIENTS WITH MET DIAGNOSTIC−POSITIVE NON−SMALL CELL LUNG CANCER (NSCLC) WHO HAVE RECEIVED STANDARD CHEMOTHERAPY FOR ADVANCED OR METASTATIC DISEASE
|
| OSU-11192 | Greg Otterson | Randomized Phase II Study of Single Agent OSI-906, an Oral, Small Molecule, Tyrosine Kinase Inhibitor (TKI) of the Insulin Growth Factor-1 Receptor (IGF-1R) Versus Topotecan for the Treatment of Patients with Relapsed Small Cell Lung Cancer (SCLC) |
| OSU-06083 | Christoph Plass | The Identification of Predisposing Genes in Chronic Lymphocytic Leukemia (CLL). |
| OSU-11127 | Leigha Senter-Jamieson | The impact of pregnancy during and after breast cancer on survival in carriers of BRCA1 and BRCA2 mutations |
| OSU-07088 | Charles Shapiro | The Columbus Breast Cancer Tissue Bank |
| OSU-06070 | Stephan Tanner | Genetic Classification of Juvenile Cobalamin Deficiency. |
| OSU-07014 | Amanda Toland | Genetic Modifiers of Breast and Ovarian Cancer Risk |
| OSU-05078 | Amanda Toland | Genomic Analysis of Squamous Cell Carcinoma |
| OSU-05082 | Amanda Toland | Variants in High Risk Breast Cancer Genes and Contribution to Cancer Risk. |
| OSU-05102 | Amanda Toland | Identification of Human Cancer Susceptibility & Resistance Genes. |
| OSU-05092 | James Van Brocklyn | The Role Shingosine Kinase in Astrocytic Gliomas. |
| OSU-12020 | Robert Wesolowski | MINT I Multi-Institutional Neo-adjuvant Therapy MammaPrint project I |
| CALGB-40903 | Lisa Yee | PHASE II STUDY OF NEOADJUVANT LETROZOLE FOR POSTMENOPAUSAL WOMEN WITH ESTROGEN RECEPTOR POSITIVE DUCTAL CARCINOMA IN SITU [DCIS) |